This site is intended for healthcare professionals only
LoginRegister
USFDA concludes inspection at Zydus Lifesciences SEZ II, Ahmedabad plantUSFDA inspection: Zydus gets EIR for Dabhasa API manufacturing facility
Biocon, NCSM partnerBiocon Foundation in collaboration with BeST Cluster, NCBS introduces BioWISE Program - to Empower...
Granules India arm gets 1 USFDA observation for Hyderabad facilityUSFDA classifies OneSource Bangalore drug-device combination facility as VAI
Merck, Daiichi Sankyo Ifinatamab deruxtecan granted Breakthrough Therapy Designation by USFDA for pretreated extensive-stage small cell lung cancerMerck RSV antibody Enflonsia gets USFDA okay for infants
positive phase 3 trialMerck posts positive phase 3 trials results evaluating Enlicitide Decanoate in adults with...
Praveen Rao AkkinepallyAstraZeneca Pharma India names Praveen Rao Akkinepally as new MD, succeeding Dr Sanjeev Panchal
Illegal drugs manufacturing unit busted in HaridwarIllegal drugs manufacturing unit busted in Haridwar
Sanofi successfully prices euro 1.5 billion bond issueSanofi-Regeneron Dupixent data reinforce use in atopic dermatitis patients with skin of color
Bayer Gets CDSCO Committee Nod to Manufacture, Market Darolutamide 300 mg for mHSPC, PMS Study MandatedSimultaneous treatment start with Finerenone and SGLT-2-inhibitor demonstrated positive data in...
Banned drug seized in KarimnagarBanned medicated soap found in Karimnagar medical shop raid
Bayer Nubeqa gets EU approvalCDSCO Panel Approves Bayer's Real-World Use Study for Heart Failure Drug Vericiguat
CDSCO Panel Clears AstraZenecas Datopotamab for Breast Cancer, Seeks Phase IV TrialCDSCO Panel Approves Updated Prescribing Information for AstraZeneca's Rosuvastatin (Crestor)
X